Patent · US Active

Ligand-conjugated monomers

US9453222B2 · kind B2 · utility

3Cited by
6References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 24, 2014
Grant dateSep 27, 2016
Priority date—
Expiry dateDec 24, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/51
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates composition and methods for making and using chemically modified oligonucleotides agents for inhibiting gene expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.